TABLE 1.

MIC of ciprofloxacin of the parental strain PAK and clones from samples exposed to either ciprofloxacin, or phages, or their combination in the HFIM during 72 h^a

Bacteria source	MIC (μg/mL)
Inoculum	0.064
HFIM (72 h samples)
Control (n = 1)	0.064
Ciprofloxacin (n = 2)	16; 16
LUZ19v (n = 2)	0.128; 0.128
PAK_P1 (n = 2)	0.064; 0.064
LUZ19v and PAK_P1 (n = 2)	0.064:0.064
Simultaneous combination of ciprofloxacin and phages (n = 2)	NBRb
Delayed combination of ciprofloxacin and phages (n = 2)	NBRb
Simultaneous combination of ciprofloxacin and phages (n = 2)	1; 2
Delayed combination of ciprofloxacin and phages (n = 2)	NBRb

^aGray lines correspond to experiments performed with an inoculum of 8 log₁₀ CFU/mL.

^bNBR, no bacteria recovered.